Quick Answer
Mosaic ImmunoEngineering Inc. reported Operating Income Loss of -$879.7 thousand for the year ending 2024.
- Mosaic ImmunoEngineering Inc. showed an increase of +37.2% in Operating Income Loss from 2023 to 2024.
- This data is from Mosaic ImmunoEngineering Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2021 to 2024), Mosaic ImmunoEngineering Inc.'s Operating Income Loss has grown by 74.9%.
- Historical annual values: Fiscal year 2024: -$879.7 thousand | Fiscal year 2023: -$1.40 million | Fiscal year 2022: -$2.63 million | Fiscal year 2021: -$3.50 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: